Customized Choice of Oral P2Y12 Receptor Blocker

计划入组 4,000 人 · 首次发布于 2011 年 11 月 23 日

A Phase 1 Study of LY2874455 in Participants With Advanced Cancer

计划入组 94 人 · 首次发布于 2010 年 9 月 30 日

Mineralocorticoid Receptor, NMDA Receptor and Cognitive Function in Depression

计划入组 232 人 · 首次发布于 2017 年 2 月 23 日

P2Y12 receptor antagonists

docitaxel (Receptor)

TrkB receptor-agonizing mAbs (Wyeth)

Arvinas Estrogen Receptor, Inc.

United States

Arvinas Androgen Receptor, Inc.

United States

Veru Inc

United States

Uni-Bio Science Group's Diquafosol Sodium Eye Drops Receives NMPA Approval for Dry Eye Syndrome Treatment in China

Real-World Study Affirms Palbociclib's Efficacy in Chinese HR+/HER2- Metastatic Breast Cancer Patients

Palbociclib Plus Letrozole Significantly Extends Progression-Free Survival in ER+ Breast Cancer